Biopharmaceutical Third Party Logistics (3PL) Market In-depth Research on Industry Size, Trends, Emerging Growth Factors and Regional Forecasts to 2025
The global Biopharmaceutical Third Party Logistics (3PL) Market size is expected to reach USD 120.64 billion by 2025, at a CAGR 4.9% over the forecast period, according to a new report by Grand View Research, Inc.
94105(firmenpresse) - The Report Biopharmaceutical Third Party Logistics (3PL) Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Region, And Segment Forecasts, 2019 – 2025
The global Biopharmaceutical Third Party Logistics (3PL) Market size is expected to reach USD 120.64 billion by 2025, at a CAGR 4.9% over the forecast period, according to a new report by Grand View Research, Inc. The market for biopharmaceutical third party logistics (3PL) is majorly driven by rising demand for temperature controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales. Rising adoption of automated storage and retrieval systems in the emerging countries is an ongoing trend in the pharmaceutical logistics companies that has gained a significant traction.
Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature sensitive products, demand for temperature controlled transportation and storage increases and thus is responsible for the market growth. As of now, the pharmaceutical sales through distributors have grown from USD 304.6 billion in 2013 to USD 440.2 billion in 2016. However, the average number of manufacturers per distributor had declined from 1,474 in 2014 to 1,211 in 2016. This data depicts that there is an increase in quantity of pharmaceutical products being distributed, and thus, is expected to surge the demand for 3PL services.
Additionally, environmental concerns and cost have caused a slight shift in the means of transport used for commercial product, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). The intermodal transport is majorly used by these pharmaceutical companies to reduce the carbon footprint. The ongoing trend shows that the pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factor. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.
Access Research Report of Biopharmaceutical Third Party Logistics (3PL) Market (at) www.grandviewresearch.com/industry-analysis/biopharmaceutical-third-party-logistics-3pl-market
Further key findings from the report suggest:
In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
Warehousing and storage held the largest market share among the types of services in 2018
Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic
Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and Agility
Themen in dieser Pressemitteilung:
biopharmaceutical-third-party-logistics-3pl-market
biopharmaceutical-third-party-logistics-3pl-industry
biopharmaceutical-third-party-logistics-3pl-market-2019
biopharmaceutical-third-party-logistics-3pl-market-size
Unternehmensinformation / Kurzprofil:
Datum: 05.12.2019 - 08:20 Uhr
Sprache: Deutsch
News-ID 603463
Anzahl Zeichen: 3780
contact information:
Contact person: Sonali Kulkarni
Town:
San Francisco
Phone: 14153490058
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: please
type of sending: don't
Diese Pressemitteilung wurde bisher 193 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biopharmaceutical Third Party Logistics (3PL) Market In-depth Research on Industry Size, Trends, Emerging Growth Factors and Regional Forecasts to 2025 "
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
